Hypertension Detection and Compliance: Permanent Site Hypertensive Evaluation—A New Method of Increasing Patient Compliance

Abstract

Screening is successful in detecting hypertension, but reducing morbidity and mortality depends on achieving patient compliance. Cardiovascular disease has declined significantly since the thiazide diuretics have become generally available and provided effective and safe treatment of hypertension. More people are now aware of their blood pressure, and more hypertensive people are under treatment than ever before. Unfortunately many are not being treated— or if treated, they are not receiving adequate therapy.

After several years of experimentation in screening, the concept of per manent site hypertension evaluation with an automatic recording device was instituted in a pharmacy. Detection during the first year in 926 people revealed that 51 % were hypertensives. There were 17% with mild hypertension, 9% with moderate hypertension, and 25% under treatment. Those under treatment were assumed to be hypertensive—normal being considered 140/90, and hyperten sive 160/100. Those between were considered mild hypertensives. After the second year, 1726 people had been screened and hypertension was detected in 48%; 18% had mild hypertension, 10% had more severe hypertension, and 20% were being treated.

Compliance was measured in two groups of patients. Short-term compliance (up to 6 months) was measured in 441 patient revisits: initially 16% were normotensive, but on revisit after 6 months, 37% were normotensive—a reduc tion in mild hypertension from 52% to 33%. Long-term compliance (6 months to 2 years) was measured in 402 patient revisits: initially 19% were normotensive, and on revisit 32%—an increase in compliance with a reduction from 48% to 35% in mild hypertension.

A new method, permanent site hypertension evaluation with patient revisits, is suggested as a new way of increasing patient compliance. The presence of normotension is assumed to mean compliance. The easy availability of per manent sites may induce the patient to return regularly, or the patient may be testing the medication or his physician. Whatever the case, normotension is the aim of compliance.

Get full access to this article

View all access options for this article.

References

Stamler, J. , Stamler, R. , Riedlinger, W.F. , et al.: Hypertension screening of 1 million Americans: Community hypertension evaluation clinic (CHEC) program, 1973 through 1975. J.A.M.A. , 235: 2299-2306, 1976.

Life Insurance Statistics: Charts prepared by the Statistical Bureau of Metropolitan Life Insurance Co. from experience of 26 companies in insuring 4 million from 1935 to 1954.

Pollner, F. : C-V mortality declines: Deaths below 1 million. Provisional data for 1975 from Nat'l. Center for Health Statistics. Int. Med. News , 9: 1, 1976.

National Center for Health Statistics : Blood pressure of adults by age and sex, United States, 1960- 62. Washington, D.C., U.S. Dept. of Health, Education & Welfare, Vital and Health Statistics Series 11, No. 4, U.S. Government Printing Office, 1964 .

Veterans Administration Cooperative Study Group on Antihypertensive Agents : Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. J.A.M.A., 213: 7, 1970.

Hutchison, J.C. , Wilkinson, W. , Karabell , S. : Current trends in the therapy of mild hypertension . Scientific Exhibit, 1970.

Oxman and Connolly : Prevention of heart disease by treatment of hypertension. Presented at the American Heart Association meeting in Dallas, Texas, 1972.

Moser, M. : Management of hypertension: The problem of physician adherence. J.A.M.A., 235: 2297, 1976.

Podell, R.N. , Gary, L.R. : Compliance: A problem in medical management . Am. Fam. Physician, 13: 74-80, 1976.

10.

Inui, T.S. , Yourtee, E.L. , Williamson, J.W. : Improved outcomes in hypertension after physician tutorials. Ann. Intern. Med., 84: 646-651, 1976.

11.

Mazzullo, J.M. : Methods of improving patient compliance. Drug Therapy, 3: 148-155, 1976.

12.

Fleckenstein, L. , Horvitz, R.A. , Morgan , J.P. : Prescription labeling as a factor in patient compliance. Drug Therapy, 5: 81-86, 1976.

13.

Smith, M.C. : How drug costs affect patient compliance. Drug Therapy, 11: 87-91, 1976.

14.

Guidelines for Patient Motivation. U.S. Dept. of H.E.W. NIH 744: 17, 1976.

15.

Grissom, R.L. , Gibbs, G.E. : Helping the hypertensive patient to help himself. J. Fam. Practice, 3: 377-379, 1976.

16.

Podell, R.N. , Kent, D. , Keller , K. : Patient psychological defenses and physician response in the long-term treatment of hypertension . J. Fam. Practice, 3: 145-149, 1976.

17.

Becker, M.H. : Facets of compliance: Strategies for improvement . Drug Therapy, 2: 139-145, 1976.

18.

Moser, M. : The liberated hypertensive. Medcom, 1975.

19.

Instructions to patient for measuring his own blood pressure . Patient Care, 4: 147, 1973.

20.

Finnerty, F.A. , Jr., Mattie, E.C. , Finnerty , F.A. III: Hypertension in the inner city. I. Analysis of clinic dropouts. Circulation , 47: 73, 1973.

21.

Kinlaw, W.B. , Hutchison, J.C. : Multiphasic Screening in Low Income Communities, Montgomery County. American Heart Association, 1971.

22.

New York Heart Association Criteria Committee : Criteria for Electrocardiograms Interpretation. Sixth edition. 1954.

23.

Hutchison, J.C. , Kinlaw, W.B. : Hypertensive screening by automatic blood pressure machine—local department stores. Unpublished report of Montgomery County Branch, American Heart Association , 1973.

24.

Hutchison, J.C. : Hypertension: A Practitioner's Guide to Therapy. Medical Exam Publishing, 1975.

25.

Hutchison, J.C. : The simultaneous comparison of the USM-105 pulse detector machine and audible readings obtained with a mercury manometer and stethoscope in 100 consecutive patients. Unpublished report.

26.

Hutchison, J.C. , Kinlaw, W.B. , Yudis , M. : Hypertensive machine screen program. Presented at the Eastern Regional Meeting of American College of Physicians. Hershey, Pennsylvania , 1974.